Skip to main content
Clinical Trials/NCT07576790
NCT07576790Not yet recruitingNot Applicable

Evaluation of Balloon Guide Catheter as Proximal Protection During Carotid Artery Stenting: A Randomized Study (EMBO-PROTECT)

Instituto de Investigación Marqués de Valdecilla0 sites126 target enrollmentStarted: July 1, 2026Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
126

Study Overview

Brief Summary

Carotid angioplasty and stenting (CAS) is an effective treatment for carotid artery stenosis but carries a risk of cerebral embolization. This prospective randomized study evaluates the safety and efficacy of proximal embolic protection using a balloon guide catheter during CAS by comparing the incidence of diffusion-weighted MRI-detected microembolisms and symptomatic thromboembolic events between protected and unprotected procedures.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Masking Description

Outcome assessors (neurologists and radiologists evaluating diffusion-weighted MRI images) are blinded to treatment allocation. Participants and interventional staff are not blinded due to the nature of the procedure.

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Age ≥ 18 years
  • Symptomatic or asymptomatic carotid artery stenosis
  • Candidate for carotid artery stenting
  • Written informed consent provided

Exclusion Criteria

  • Vascular anatomy unsuitable for balloon guide catheter placement
  • Severe renal failure
  • Previous disabling stroke or symptomatic intracranial hemorrhage
  • Evidence of carotid thrombus
  • Severe common carotid artery lesion
  • Chronic atrial fibrillation on oral anticoagulation
  • Acute coronary syndrome within 30 days
  • Contraindications to anticoagulant or antiplatelet therapy
  • Contraindications to MRI
  • Contrast media allergy
  • Lack of prior dual antiplatelet therapy

Investigators

Sponsor
Instituto de Investigación Marqués de Valdecilla
Sponsor Class
Other
Responsible Party
Sponsor

Similar Trials